AUG 04, 2017 12:43 PM PDT

A Molecule Could Stop Lung Cancer Metastasis to the Brain

WRITTEN BY: Carmen Leitch
One reason cancer is so deadly is that cancer cells can break away from where they originated and spread disease throughout the body. Stopping metastasis is a major goal in cancer therapeutics. Researchers have now found a molecule that might be able to stop lung cancer from spreading to the brain. This molecule, CD15s, allows metastatic lung cancer cells to bind to blood vessels inside the brain, where they can get a foothold.
 
A brain tumor / Credit: Brain Tumor Research
 
Cancerous cells cannot just enter the brain; they have to attach to cells of the blood-brain barrier – a protective sheath that keeps the brain separated from blood circulating in the body. Researchers at the University of Portsmouth's Brain Tumor Research Centre of Excellence wanted to know more about how this process is facilitated and to see if it could be disrupted. Their findings have been published in the International Journal of Molecular Sciences.
 
This work focused on non-small cell lung cancer (NSCLC); around 30 percent of people affected by NSCLC will go on to have brain metastasis. NSCLC cells have various features on their surface that can give them a sticky property, and can determine whether or not they will bind to other cells.
 
By closely investigating these features on the cells, the investigators found that the CD15s gene is highly expressed in metastatic tumor cells, including those disseminating from lung cancer. The gene is only expressed at low levels in lung cancer cells that stay in the lung and do not migrate.
 
When the scientists blocked CD15s from being expressed on the tumor cell surface, NSCLC cells could not attach to blood vessels. This work suggests that if the action of CD15s can be blocked, it may be possible to stop metastasis in the brain, and maybe in other cancers.
 
"Although this work is still at an early stage, we have demonstrated key elements that are associated with tumor cell binding to blood vessels, and this may provide a target for future drug development to prevent the development of secondary tumors in the brain," explained Geoff Pilkington, a co-author of the report and a Professor of Cellular & Molecular Neuro-Oncology. "Increasing our understanding of the adhesive properties of tumors may also help to develop new treatments to halt the development and spread of primary brain tumors," he continued.
 
Adhesion is critically important in cancer; when cells are tightly bound during the development of low-grade tumors, as malignancy increases the cells become less adhesive. The cancerous cells are then free to migrate to other areas. Therapeutics would benefit from a complete understanding of cell adhesion in cancer.
 
"Brain tumors kill more children and adults under the age of 40 than any other cancer, yet just one percent of the national spend on cancer research has been allocated to this devastating disease. We are funding vital research in the UK to address this situation and are encouraged by Professor Pilkington's findings," commented Dr. Kieran Breen, the Director of Research at Brain Tumor Research.
 
 
 

 

Learn more about brain tumors from Professor Pilkington, the Head of the Brain Tumor Research Centre who is featured in the above video.
 
About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
NOV 17, 2018
Genetics & Genomics
NOV 17, 2018
Joubert Syndrome Model Successfully Treated with Gene-editing
A life-threatening kidney disease may be one day be a treatable condition thanks to new work by researchers, and patients with the illness....
NOV 18, 2018
Neuroscience
NOV 18, 2018
How does the brain know when we are full?
Feeling full or satiation is conveyed to the brain by the gut hormones via the enteric neuronal afferents and the endocrine feedback pathways....
NOV 20, 2018
Cell & Molecular Biology
NOV 20, 2018
A Warning About Using Epigenetic Modifiers as Therapeutic Targets
In the long run, some cancer therapeutics may be doing more harm than good....
DEC 04, 2018
Genetics & Genomics
DEC 04, 2018
The Fallout From the First CRISPR Babies Continues
Last week the world was stunned to hear that twin babies had been born after a gene-editing experiment was conducted on human embryos....
DEC 08, 2018
Cardiology
DEC 08, 2018
Atrial Fibrillation, Explained
Atrial fibrillation (A-Fib) is a term you've likely heard before. You may have even been told you live with A-Fib. What exactly is this common type of...
DEC 10, 2018
Neuroscience
DEC 10, 2018
Researchers Found Future Choice Predictive Neural Activity In The Prefrontal Cortex
Uncertainty and Gambling go hand-in-hand; there is never a sure bet. Researchers have identified neuronal activity in the prefrontal cortex that encodes predictive action....
Loading Comments...